Dermatology drugs market- Segmented By Product Type, End-Use Type and Geography – Growth, Trends & Forecast, 2026

20/gen/2021 10:39:53 MonicaK Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.


Polaris Market Research assumes that with the expected launch of the potential promising therapies, the market is anticipated to expand in both psoriasis and atopic dermatitis segments. The Unites States accounts for the higher share of the market as compared to the Europe and Japan. The highest market size is due to the increased adoption of high priced biologics. Despite the launch and availability of multiple biologics, only 10% of the patients have access to these treatments and the market continues to remain underpenetrated.


Get sample copy of this report @


Currently, the dermatology drugs market is highly fragmented but offer several commercial opportunities. There remains significant unmet need for safer and cost-effective treatment options. Psoriasis market was nearly USD 6 billion markets in 2016 due to the existing effective TNF alpha treatments. In Acne, retinoids and antibiotics are the mainstay treatments but what makes this indication lucrative is the promising candidates in the pipeline including Foamix’s FMX-101 and Dermira’s DRM-101.


Polaris Market Research has provided the forecasts of the Global Dermatology Drugs Market from 2016-2022. The major segments which has been investigated in the global market from 2016-2022 are:

·         Market Analysis by Dermatology Key Indications

·         Market Analysis by Treatment Class/Marketed Drugs

·         Market Analysis by Regions

Complete Summary with TOC Available @  


The Marketed Therapies undertaken in forecast from 2016-2022 are: 

·         etanercept; Enbrel

·         infliximab; Remicade

·         adalimumab; Humira

·         ustekinumab; Stelara

·         secukinumab; Cosentyx

·         ixekizumab; Taltz

·         golimumab; Simponi

·         brodalumab; Siliq

·         guselkamab; Tremfya

·         Topical Drugs

·         Oral Antibiotics


The Major Indications in Dermatology Therapy area:

·         Atopic Dermatitis

·         Psoriasis

·         Acne

·         Rosacea


Leading Companies investigated in the Report are: 

·         Allergan Plc

·         Valeant Pharmaceuticals

·         Dermira Inc

·         Aclaris Therapeutics, Inc

·         AnaptysBio, Inc

·         Revance Therapeutics

·         Foamix Pharmaceuticals

·         Novan, Inc

·         Sienna Biopharmaceuticals

·         Pfizer

·         Sanofi

·         Galderma

·         Leo Pharma

·         Roviant Sciences

·         Otsuka Pharmaceuticals


Avail discount on this report @

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world.


Contact us-

Polaris Market Research

Phone: 1-646-568-9980





blog comments powered by Disqus è un servizio offerto da Factotum Srl